Select Medical (NYSE:SEM) Releases FY24 Earnings Guidance

Select Medical (NYSE:SEM) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $1.96-2.20 for the period, compared to the consensus estimate of $2.12. The company issued revenue guidance of $6.9-7.1 billion, compared to the consensus revenue estimate of $7.01 billion. Select Medical also updated its FY 2024 guidance to 1.960-2.200 EPS.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Royal Bank of Canada increased their target price on shares of Select Medical from $36.00 to $40.00 and gave the company an outperform rating in a research note on Monday, May 6th. Benchmark restated a buy rating and issued a $48.00 price target on shares of Select Medical in a research report on Friday. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of Moderate Buy and a consensus target price of $36.50.

Select Medical Stock Down 12.8 %

Shares of Select Medical stock traded down $5.00 during midday trading on Friday, reaching $34.18. 2,367,259 shares of the company’s stock traded hands, compared to its average volume of 708,812. The company has a market cap of $4.44 billion, a price-to-earnings ratio of 16.28, a price-to-earnings-growth ratio of 1.78 and a beta of 1.43. The company’s 50 day simple moving average is $35.77 and its 200 day simple moving average is $31.13. The company has a debt-to-equity ratio of 2.30, a quick ratio of 1.22 and a current ratio of 1.22. Select Medical has a 52 week low of $21.28 and a 52 week high of $40.50.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.01. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.91% and a return on equity of 17.88%. Select Medical’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.61 EPS. Equities analysts expect that Select Medical will post 2.19 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th will be issued a dividend of $0.125 per share. The ex-dividend date of this dividend is Wednesday, August 14th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.46%. Select Medical’s dividend payout ratio is currently 23.81%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.